ELV · Elevance Health, Inc.
Healthcare NYQ United States elevancehealth.com ↗
BULLISH BUY
Val Gro Qua Mom Sta Cap P/S0.41 P/E Fwd P/E12.69 PEG1.34 52W –  RSI Target$449.1 (+19.4%) Beta0.68 Div1.78%
Loading chart…
RSI (14)
Pattern Overlays
Loading patterns…
Healthcare Plans Indianapolis, United States 96,129 employees
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 42 Overbought · 100
Signal Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
3Bullish
1Bearish
0Neutral
▲ Bull Flag — Breakout after +9% pole — bullish continuation
▲ Bull Flag — Breakout after +27% pole — bullish continuation
▲ Bull Flag — Breakout after +28% pole — bullish continuation
▼ Double Top — Two peaks ~$431.61 — bearish reversal confirmed

View overlays on the price chart via Chart tab → Pattern Overlays.

Next Earnings Oct 21, 2026
Beat Rate 62%
Consensus BUY
Analyst Upside +19.4%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
62% 5/8 quarters
Wall Street Consensus
BUY
15
7
BuyHoldSell
Price Target Range
$449.1 +19.4% upside
Low $393 High $492
Consensus Current price
Wall Street Analyst Ratings
FirmRatingChangeActionDate
Leerink Partners Market Perform ↔ Maintain 2026-07-17
RBC Capital Sector Perform ↔ Maintain 2026-07-16
Wells Fargo Overweight ↔ Maintain 2026-07-16
Guggenheim Buy ↔ Maintain 2026-07-16
Barclays Overweight ↔ Maintain 2026-07-16
Baird Neutral ↔ Maintain 2026-07-16
TD Cowen Buy ↔ Maintain 2026-07-14
Truist Securities Buy ↔ Maintain 2026-07-14
Cantor Fitzgerald Overweight ↔ Maintain 2026-07-07
Bernstein Outperform ↔ Maintain 2026-07-02
Mizuho Outperform ↔ Maintain 2026-06-08
JP Morgan Overweight ↔ Maintain 2026-06-08
B of A Securities Buy ↔ Maintain 2026-06-04
Morgan Stanley Equal-Weight ↔ Maintain 2026-06-04
UBS Buy ↔ Maintain 2026-05-22
Deutsche Bank Buy Hold Buy ▲ Upgrade 2026-05-20
Evercore ISI Group In-Line ↔ Maintain 2026-04-23
Jefferies Buy ↔ Maintain 2026-04-20
Wolfe Research Outperform Peer Perform Outperform ▲ Upgrade 2026-01-08
Leerink Partners 2026-07-17
Market Perform ↔ Maintain
RBC Capital 2026-07-16
Sector Perform ↔ Maintain
Wells Fargo 2026-07-16
Overweight ↔ Maintain
Guggenheim 2026-07-16
Buy ↔ Maintain
Barclays 2026-07-16
Overweight ↔ Maintain
Baird 2026-07-16
Neutral ↔ Maintain
TD Cowen 2026-07-14
Buy ↔ Maintain
Truist Securities 2026-07-14
Buy ↔ Maintain
Cantor Fitzgerald 2026-07-07
Overweight ↔ Maintain
Bernstein 2026-07-02
Outperform ↔ Maintain
Mizuho 2026-06-08
Outperform ↔ Maintain
JP Morgan 2026-06-08
Overweight ↔ Maintain
B of A Securities 2026-06-04
Buy ↔ Maintain
Morgan Stanley 2026-06-04
Equal-Weight ↔ Maintain
UBS 2026-05-22
Buy ↔ Maintain
Deutsche Bank 2026-05-20
Buy (from Hold) ▲ Upgrade
Evercore ISI Group 2026-04-23
In-Line ↔ Maintain
Jefferies 2026-04-20
Buy ↔ Maintain
Wolfe Research 2026-01-08
Outperform (from Peer Perform) ▲ Upgrade
Profitability
Gross Margin 25.99%TTM
Op. Margin 4.56%TTM
ROE 11.13%TTM
Rev. Growth 1.40%YoY
Free Cash Flow 4.31BTTM
FCF Yield TTM
Balance Sheet
Debt / Equity 68.95MRQ
Current Ratio 1.52MRQ
Cash 37.51BMRQ
Total Debt 31.04BMRQ
Net Debt MRQ
Income
Div. Yield 1.78%TTM
Annual Rate 6.88Fwd
Payout Ratio 30.34%TTM
Dividend History
Payout Ratio (TTM): 30.34%
DateAmount / ShareYield at Payment
2026-06-10 $1.7200 0.42%
2026-03-10 $1.7200 0.61%
2025-12-05 $1.7100 0.52%
2025-09-10 $1.7100 0.57%
2025-06-10 $1.7100 0.46%
2025-03-10 $1.7100 0.43%
2024-12-05 $1.6300 0.43%
2024-09-10 $1.6300 0.31%
2024-06-10 $1.6300 0.32%
2024-03-07 $1.6300 0.34%
2023-12-05 $1.4800 0.32%
2023-09-07 $1.4800 0.34%
2023-06-08 $1.4800 0.33%
2023-03-09 $1.4800 0.34%
2022-12-02 $1.2800 0.26%
2022-09-08 $1.2800 0.28%
2022-06-09 $1.2800 0.28%
2022-03-09 $1.2800 0.29%
2021-12-02 $1.1300 0.30%
2021-09-09 $1.1300 0.33%
2021-06-09 $1.1300 0.32%
2021-03-09 $1.1300 0.36%
2020-12-04 $0.9500 0.32%
2020-09-09 $0.9500 0.39%
2020-06-09 $0.9500 0.35%
2020-03-13 $0.9500 0.38%
2019-12-04 $0.8000 0.30%
2019-09-09 $0.8000 0.35%
2019-06-07 $0.8000 0.32%
2019-03-15 $0.8000 0.29%
2018-12-04 $0.7500 0.28%
2018-09-07 $0.7500 0.31%
2018-06-07 $0.7500 0.36%
2018-03-08 $0.7500 0.37%
2017-12-04 $0.7000 0.35%
2017-09-07 $0.7000 0.41%
2017-06-07 $0.6500 0.39%
2017-03-08 $0.6500 0.45%
2016-12-01 $0.6500 0.51%
2016-09-07 $0.6500 0.59%
How ELV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap81.54B
Enterprise Value75.21B
Trailing P/E16.64
Forward P/E12.69
PEG Ratio (5yr)1.34
Price/Sales (ttm)0.41
Price/Book (mrq)1.82
EV/Revenue0.37
EV/EBITDA9.04
Share Statistics
Avg Vol (3m)1.69M
Shares Outstanding216.87M
Float216.41M
% Held by Insiders0.19%
% Held by Institutions93.69%
Short Ratio3.47
Short % of Float3.11%
Profitability
Gross Margin25.99%
Operating Margin (ttm)4.56%
Profit Margin2.47%
Return on Assets (ttm)3.83%
Return on Equity (ttm)11.13%
Income Statement
Revenue (ttm)201.11B
Revenue Growth (yoy)1.40%
Gross Profit (ttm)52.27B
EBITDA8.32B
Net Income (ttm)4.96B
Diluted EPS (ttm)22.60
EPS Growth (yoy)-13.10%
Balance Sheet
Total Cash (mrq)37.51B
Total Debt (mrq)31.04B
Debt / Equity (mrq)68.95
Current Ratio (mrq)1.52
Book Value / Share206.99
Operating CF (ttm)7.46B
Free Cash Flow (ttm)4.31B
Trading & Dividends
Beta (5Y)0.68
50-Day MA397.84
200-Day MA350.82
Fwd Dividend Yield178.00%
Payout Ratio30.34%
Ownership Breakdown
Institutional 93.69% Insider 0.19% Public 6.1%
Short Interest 3.11% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in ELV in their latest SEC 13F filing.

Loading…
Insider Transactions
DateInsiderRoleTransactionSharesValue
2026-07-17 PERU RAMIRO G Director Purchase at price 366.05 per share. 1,000 $366,050
2026-07-17 BOUDREAUX GAIL A KOZIARA Chief Executive Officer Purchase at price 366.41 - 368.25 per share. 2,725 $1,002,230
2026-06-12 PENCZEK RONALD W Officer Sale at price 403.16 per share. 369 $148,766
2026-06-11 DIXON ROBERT L JR Director Sale at price 401.77 per share. 151 $60,667
2026-05-19 PENCZEK RONALD W Officer Sale at price 403.13 per share. 1,531 $617,192
2026-05-19 PENCZEK RONALD W Officer Conversion of Exercise of derivative security at price 271.27 - 311.48 per share. 1,531 $450,579
2026-05-13 HAY LEWIS III Director Stock Award(Grant) at price 0.00 per share. 563
2026-05-13 JALLAL BAHIJA Director Stock Award(Grant) at price 0.00 per share. 563
2026-05-13 PERU RAMIRO G Director Stock Award(Grant) at price 0.00 per share. 563
2026-05-13 COLLIS STEVEN HOWARD Director Stock Award(Grant) at price 0.00 per share. 563
2026-05-13 DIXON ROBERT L JR Director Stock Award(Grant) at price 0.00 per share. 563
2026-05-13 DEVORE SUSAN D Director Stock Award(Grant) at price 0.00 per share. 563
2026-05-13 SCHULMAN AMY W. Director Stock Award(Grant) at price 0.00 per share. 563
2026-05-13 STRABLE-SOETHOUT DEANNA D Director Stock Award(Grant) at price 0.00 per share. 563
2026-05-13 NERI ANTONIO F Director Stock Award(Grant) at price 0.00 per share. 563
2026-05-13 SCHNEIDER RYAN M. Director Stock Award(Grant) at price 0.00 per share. 563
2026-03-12 SCHULMAN AMY W. Director Sale at price 287.50 per share. 26 $7,475
2026-03-06 KENDRICK CHARLES MORGAN JR Officer Sale at price 284.92 per share. 3,196 $910,604
2026-03-05 COLLIS STEVEN HOWARD Director Purchase at price 289.84 per share. 3,000 $869,520
2026-03-02 KENDRICK CHARLES MORGAN JR Officer Stock Award(Grant) at price 0.00 per share. 6,549
2026-03-02 CRAIG RYAN R Officer Stock Award(Grant) at price 0.00 per share. 2,976
2026-03-02 WESSLING ERIN M Officer Stock Award(Grant) at price 0.00 per share. 2,976
2026-03-02 LAVU RATNAKAR Chief Technology Officer Stock Award(Grant) at price 0.00 per share. 11,903
2026-03-02 NORWOOD FELICIA F. Officer Stock Award(Grant) at price 0.00 per share. 8,816
2026-03-02 KAYE MARK Chief Financial Officer Stock Award(Grant) at price 0.00 per share. 16,579
PERU RAMIRO G Director
Purchase at price 366.05 per share.
2026-07-17 1,000 sh $366,050
BOUDREAUX GAIL A KOZIARA Chief Executive Officer
Purchase at price 366.41 - 368.25 per share.
2026-07-17 2,725 sh $1,002,230
PENCZEK RONALD W Officer
Sale at price 403.16 per share.
2026-06-12 369 sh $148,766
DIXON ROBERT L JR Director
Sale at price 401.77 per share.
2026-06-11 151 sh $60,667
PENCZEK RONALD W Officer
Sale at price 403.13 per share.
2026-05-19 1,531 sh $617,192
PENCZEK RONALD W Officer
Conversion of Exercise of derivative security at price 271.27 - 311.48 per share.
2026-05-19 1,531 sh $450,579
HAY LEWIS III Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
JALLAL BAHIJA Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
PERU RAMIRO G Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
COLLIS STEVEN HOWARD Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
DIXON ROBERT L JR Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
DEVORE SUSAN D Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
SCHULMAN AMY W. Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
STRABLE-SOETHOUT DEANNA D Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
NERI ANTONIO F Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
SCHNEIDER RYAN M. Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13 563 sh
SCHULMAN AMY W. Director
Sale at price 287.50 per share.
2026-03-12 26 sh $7,475
KENDRICK CHARLES MORGAN JR Officer
Sale at price 284.92 per share.
2026-03-06 3,196 sh $910,604
COLLIS STEVEN HOWARD Director
Purchase at price 289.84 per share.
2026-03-05 3,000 sh $869,520
KENDRICK CHARLES MORGAN JR Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02 6,549 sh
CRAIG RYAN R Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02 2,976 sh
WESSLING ERIN M Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02 2,976 sh
LAVU RATNAKAR Chief Technology Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02 11,903 sh
NORWOOD FELICIA F. Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02 8,816 sh
KAYE MARK Chief Financial Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02 16,579 sh